tazarotene 0.0005 MG/MG Topical Gel [Tazorac]
RxNorm concept 212437, branded drug (sbd). Prescribable name: TAZORAC 0.05 % Topical Gel.
- RxCUI
- 212437
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/212437 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Tazorac 0.0005 MG/MG Topical Gel; Tazorac 0.05 % Topical Gel; Tazorac 0.5 MG in 1 GM Topical Gel
Related concepts
- tazarotene 0.0005 MG/MG (SCDC, consists of)
- tazarotene 0.0005 MG/MG [Tazorac] (SBDC, consists of)
- Topical Gel (DF, has dose form)
- Tazorac (BN, has ingredient)
- tazarotene 0.0005 MG/MG Topical Gel (SCD, tradename of)
Linked data
NDCs
- 00023833503
- 00023833510
- 16110083310
- 16110083330
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 212437 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/212437 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 212437. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.